AAME vs GILD · rev $188.2M vs P/E 18, rev $7.80B
Atlantic American Corporation (AAME) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Atlantic American Corporation (AAME) is a insurance - life company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AAME revenue for 2024-12-31 was $188.2M. Net income was -$4.3M. AAME currently screens at market cap $43.4M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AAME currently screens at market cap $43.4M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AAME and GILD stock pages for the full models.
Not investment advice.